• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Business Development Agent in Japan February 12, 2020
  • High Throughput Layout and Copy Paste July 5, 2019
  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

CTLA4

Immune checkpoint blockade in cancer immunotherapy

August 28, 2018Cancer, Cancer Immunotherapy, Vizit Graphs
Immune checkpoint blockade in cancer immunotherapy

Explore immune checkpoint blockade (PD-1, CTLA-4) in cancer immunotherapy with Biovista Vizit. Explore the live graph.

Regulatory T Cell function in cancer and inflammation

August 24, 2018Cancer, Cancer Immunotherapy, Featured, Inflammation, Microbiome, Vizit Graphs
Regulatory T Cell function in cancer and inflammation

Association of microbiome organisms to Regulatory T Cell function in cancer and inflammation. Explore the live graph.

Vizit Graphs Tag Cloud

CANCER CD4 INSULIN HELICOBACTER PYLORI 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE CASP3 TH17 CELLS LISTERIA MONOCYTOGENES SOD1 BREAST CANCER AUTOPHAGY ALZHEIMER'S DISEASE INFLAMMATION RHEUMATOID ARTHRITIS TP53 CELL DEATH APOPTOTIC PROCESS ANGIOGENESIS ERBB-2 STREPTOCOCCUS PNEUMONIAE PORPHYROMONAS GINGIVALIS CELL DIVISION DIABETES MELLITUS PARKINSON DISEASE AGING IMMUNE RESPONSE TNF CELL DIFFERENTIATION IL23A METFORMIN IL6 IL17A REMICADE ESCHERICHIA COLI CTLA4 IFNG RECEPTOR STAPHYLOCOCCUS AUREUS CELL PROLIFERATION PSEUDOMONAS AERUGINOSA CLOSTRIDIUM DIFFICILE FOXP3 DOXORUBICIN NEURODEGENERATIVE DISORDERS CANDIDA ALBICANS

© 2020 Biovista Vizit All Rights Reserved.